Autologous micro-fragmented adipose tissue injection provides significant and prolonged clinical improvement in patients with knee osteoarthritis: a case-series study.

Cells (MSCs) Knee Osteoarthritis (KOA) Mesenchymal Stem Cells or Medicinal Signalling Micro-fragmented Adipose Tissue (MAT) Minimal Clinical Important Difference (MCID)

Journal

Journal of experimental orthopaedics
ISSN: 2197-1153
Titre abrégé: J Exp Orthop
Pays: Germany
ID NLM: 101653750

Informations de publication

Date de publication:
16 Nov 2023
Historique:
received: 24 02 2023
accepted: 09 10 2023
medline: 16 11 2023
pubmed: 16 11 2023
entrez: 16 11 2023
Statut: epublish

Résumé

Among the conservative strategies to manage patients with symptomatic knee osteoarthritis (OA), an innovative approach exploiting the regenerative capability of adipose tissue and its resident MSCs (Mesenchymal Stem Cells or Medicinal Signalling Cells) has been proposed with encouraging results. This study aims to demonstrate the benefits of autologous micro-fragmented adipose tissue (MAT) injection in the conservative treatment of knee osteoarthritis and whether any variables may affect the outcome. This is a case series single-centre study in which patients underwent intraarticular MAT injection without any associated procedures. Based on inclusion and exclusion criteria, 49 patients (67 Knees) were included and retrospectively analysed with a mean follow-up of 34.04 ± 13.62 months (minimum 11 - maximum 59). Patients were assessed through the WOMAC and KOOS questionnaires at baseline (pre-treatment) and 1-, 3-, 6-, 12-, 24- and 36-month follow-up. A minimal clinically important difference (MCID) of at least 7.5 points for the WOMAC pain scale and 7.2 for the WOMAC function scale compared to the baseline value was used. WOMAC and KOOS scores improved after treatment compared to baseline at all follow-ups with p < 0.001. Male gender and Kellgren-Lawrence (KL) grade 2 were associated with smaller improvement in WOMAC and KOOS scores (with respect to females and to KL grade 1, respectively) up to 24 months. The percentage of patients who reach the MCID for WOMAC pain is generally lower than that of patients who reach the MCID for WOMAC function (around 80% at all time points), but it increases significantly over time. Moreover, the baseline score of the WOMAC pain and function influence the outcome. Patients with worse symptoms are more likely to reach the MCID. Intra-articular knee injection of MAT for the treatment of knee osteoarthritis (KOA), recalcitrant to traditional conservative treatments, proved to be effective in a high percentage of cases. The positive association between a worse pre-operative score and a better clinical response to the treatment would support the idea that intra-articular administration of MAT could be considered in patients with very symptomatic KOA in which joint-replacement surgeries are not indicated (or accepted). IV, case series.

Identifiants

pubmed: 37968496
doi: 10.1186/s40634-023-00668-y
pii: 10.1186/s40634-023-00668-y
pmc: PMC10651566
doi:

Types de publication

Journal Article

Langues

eng

Pagination

116

Informations de copyright

© 2023. The Author(s).

Références

Stem Cell Res Ther. 2019 Feb 13;10(1):58
pubmed: 30760316
Medicine (Baltimore). 2020 Dec 4;99(49):e23343
pubmed: 33285713
Am J Sports Med. 2022 Sep;50(11):2881-2892
pubmed: 35984721
Int Orthop. 2021 May;45(5):1179-1188
pubmed: 33649891
Clin Orthop Relat Res. 2018 Oct;476(10):2005-2014
pubmed: 30179956
J Exp Orthop. 2018 Dec 19;5(1):52
pubmed: 30569417
Genes (Basel). 2019 Jun 21;10(6):
pubmed: 31234442
Stem Cells Dev. 2021 Jul 1;30(13):651-659
pubmed: 33899526
J Clin Med. 2019 Mar 28;8(4):
pubmed: 30925656
N Engl J Med. 2020 Apr 9;382(15):1420-1429
pubmed: 32268027
Knee Surg Sports Traumatol Arthrosc. 2019 Jun;27(6):2003-2020
pubmed: 30159741
Stem Cells Transl Med. 2016 Jul;5(7):847-56
pubmed: 27217345
Curr Stem Cell Rep. 2016;2:304-312
pubmed: 27547712
Regen Ther. 2020 Feb 20;14:136-153
pubmed: 32110683
Cells. 2019 Apr 03;8(4):
pubmed: 30987218
Cells. 2021 Jun 01;10(6):
pubmed: 34206010
Cartilage. 2021 Dec;13(1_suppl):185S-196S
pubmed: 32186401
Osteoarthritis Cartilage. 2019 Nov;27(11):1578-1589
pubmed: 31278997
Int Orthop. 2019 Jan;43(1):7-13
pubmed: 30280218
Clin Rheumatol. 2021 Jan;40(1):263-277
pubmed: 32533337
Cartilage. 2021 Dec;13(2_suppl):225S-237S
pubmed: 33583216
Stem Cells Int. 2021 Jun 09;2021:9921015
pubmed: 34211557
Knee Surg Sports Traumatol Arthrosc. 2022 Mar;30(3):773-781
pubmed: 33464397
Genes (Basel). 2017 Oct 13;8(10):
pubmed: 29027984
Genes (Basel). 2019 Dec 17;10(12):
pubmed: 31861180
Am J Sports Med. 2019 Feb;47(2):347-354
pubmed: 30545242
Cell Transplant. 2013;22(11):2063-77
pubmed: 23051701
Int Orthop. 2019 Jan;43(1):15-23
pubmed: 30311059
BMC Musculoskelet Disord. 2020 Apr 11;21(1):224
pubmed: 32278352
Knee Surg Sports Traumatol Arthrosc. 2020 Jun;28(6):1876-1884
pubmed: 31297576
Am J Sports Med. 2017 Feb;45(2):339-346
pubmed: 28146403
Am J Sports Med. 2023 Mar;51(3):837-848
pubmed: 35019764
J Exp Orthop. 2017 Oct 3;4(1):33
pubmed: 28975547
BMC Musculoskelet Disord. 2020 Jun 23;21(1):401
pubmed: 32576163
Croat Med J. 2019 Jun 13;60(3):227-236
pubmed: 31187950
Arthritis Rheum. 2013 May;65(5):1271-81
pubmed: 23613363
BMC Musculoskelet Disord. 2018 May 30;19(1):176
pubmed: 29848328
Plast Reconstr Surg. 2013 Oct;132(4):1017-1026
pubmed: 23783059
Eur J Orthop Surg Traumatol. 2023 Jul;33(5):1895-1904
pubmed: 35997833
Stem Cell Res Ther. 2020 Nov 2;11(1):462
pubmed: 33138862
Am J Sports Med. 2020 Mar;48(3):588-598
pubmed: 32109160
Knee Surg Sports Traumatol Arthrosc. 2016 Jun;24(6):1826-35
pubmed: 27120191
Regen Med. 2019 Mar;14(3):213-230
pubmed: 30762487

Auteurs

Arcangelo Russo (A)

Department of Orthopedics, Joint Prosthetic, Arthroscopic Surgery and Sports Traumatology, Humanitas Castelli, Via Mazzini 11, 24128, Bergamo, Italy. arcangelorusso@yahoo.it.

Gabriele Cortina (G)

Department of Orthopaedic and Trauma Surgery, University Campus Bio-Medico of Rome, 00128, Rome, Italy.

Vincenzo Condello (V)

Department of Orthopedics, Joint Prosthetic, Arthroscopic Surgery and Sports Traumatology, Humanitas Castelli, Via Mazzini 11, 24128, Bergamo, Italy.

Marco Collarile (M)

Department of Orthopedics, Joint Prosthetic, Arthroscopic Surgery and Sports Traumatology, Humanitas Castelli, Via Mazzini 11, 24128, Bergamo, Italy.

Roberto Orlandi (R)

Department of Orthopedics, Joint Prosthetic, Arthroscopic Surgery and Sports Traumatology, Humanitas Castelli, Via Mazzini 11, 24128, Bergamo, Italy.

Riccardo Gianoli (R)

Engineering Department, University of Bergamo, Viale Marconi, 5, 24044, Dalmine, BG, Italy.

Emanuele Giuliani (E)

Engineering Department, University of Bergamo, Viale Marconi, 5, 24044, Dalmine, BG, Italy.

Vincenzo Madonna (V)

Department of Orthopedics, Joint Prosthetic, Arthroscopic Surgery and Sports Traumatology, Humanitas Castelli, Via Mazzini 11, 24128, Bergamo, Italy.

Classifications MeSH